DASPHARMA Stock Overview
Manufactures and sells pharmaceutical products in Ghana. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Dannex Ayrton Starwin Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | GH₵0.38 |
| 52 Week High | GH₵0 |
| 52 Week Low | GH₵0 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -5.00% |
| 3 Year Change | -5.00% |
| 5 Year Change | n/a |
| Change since IPO | -5.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| DASPHARMA | GH Pharmaceuticals | GH Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 3.0% |
| 1Y | -5.0% | -7.3% | 56.1% |
Return vs Industry: DASPHARMA exceeded the GH Pharmaceuticals industry which returned -7.5% over the past year.
Return vs Market: DASPHARMA underperformed the GH Market which returned 55.9% over the past year.
Price Volatility
| DASPHARMA volatility | |
|---|---|
| DASPHARMA Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 2.3% |
| 10% most volatile stocks in GH Market | 4.5% |
| 10% least volatile stocks in GH Market | 0.8% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine DASPHARMA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | n/a | Daniel Kwabena Kissi | dasplcgh.com |
Dannex Ayrton Starwin Plc manufactures and sells pharmaceutical products in Ghana. It offers a range of products in various categories, such as analgesics and antipyretics, hematinics, anti-tussives, anti-convulsing and anti-asthmatics, cough preparations, dermatological products, food supplements, vitamins, and minerals. The company manufactures its products in form of syrups, tablets, creams, suspensions, disinfectants, lozenges, powders, capsules, and emulsions.
Dannex Ayrton Starwin Plc Fundamentals Summary
| DASPHARMA fundamental statistics | |
|---|---|
| Market cap | n/a |
| Earnings (TTM) | GH₵0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs DASPHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DASPHARMA income statement (TTM) | |
|---|---|
| Revenue | GH₵0 |
| Cost of Revenue | GH₵0 |
| Gross Profit | GH₵0 |
| Other Expenses | GH₵0 |
| Earnings | GH₵0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DASPHARMA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:10 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dannex Ayrton Starwin Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|